Outsourcing

Feb 23, 2018
By BioPharm International Editors
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
Feb 22, 2018
By BioPharm International Editors
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.
Feb 22, 2018
By BioPharm International Editors
The company aims to add the additional analytical services in the European Union throughout 2018.
Feb 13, 2018
By BioPharm International Editors
A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.
Feb 13, 2018
By BioPharm International Editors
Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.
Feb 12, 2018
By BioPharm International Editors
The companies have been awarded a collaborative grant of £1.9 million (US$2.6 million) from Innovate UK.
Feb 01, 2018
BioPharm International
Greater clarity on the application of existing regulations will accelerate development of cell and gene therapies.
Feb 01, 2018
BioPharm International
Frustrated with high costs and drug shortages, hospitals adopt a DIY approach.
Feb 01, 2018
BioPharm International
Layout and supply details must be considered when implementing a fully disposable biopharmaceutical manufacturing process.
Feb 01, 2018
By BioPharm International Editors
Biopharm industry veteran Ralf Otto named to lead development and manufacturing at Rentschler Biopharma.
native1_300x100
lorem ipsum